Miho Yano

435 total citations
10 papers, 342 citations indexed

About

Miho Yano is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Miho Yano has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Miho Yano's work include Diabetes Treatment and Management (2 papers), Advanced Glycation End Products research (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Miho Yano is often cited by papers focused on Diabetes Treatment and Management (2 papers), Advanced Glycation End Products research (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Miho Yano collaborates with scholars based in Japan. Miho Yano's co-authors include Goji Hasegawa, Michiyo Ishii, Takeo Yoshikawa, Hiroshi Obayashi, Naoto Nakamura, A. Kitamura, Michiaki Fukui, Naoto Nakamura, Masahiro Yamasaki and Toshikazu Yoshikawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetic Medicine.

In The Last Decade

Miho Yano

10 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miho Yano Japan 7 83 72 71 62 48 10 342
Chie Kawahara Japan 10 76 0.9× 55 0.8× 77 1.1× 68 1.1× 69 1.4× 18 398
Carin Gustavsson Sweden 10 83 1.0× 70 1.0× 107 1.5× 59 1.0× 29 0.6× 15 476
Hui Yi China 9 48 0.6× 45 0.6× 81 1.1× 41 0.7× 32 0.7× 14 357
Suzanne Droesch France 9 62 0.7× 60 0.8× 67 0.9× 28 0.5× 46 1.0× 9 388
Barbara Lewko Poland 13 42 0.5× 41 0.6× 121 1.7× 51 0.8× 38 0.8× 25 420
Jun-Te Hsu United States 12 74 0.9× 89 1.2× 130 1.8× 22 0.4× 54 1.1× 16 439
T Okanoue Japan 6 171 2.1× 67 0.9× 67 0.9× 44 0.7× 29 0.6× 10 534
Yoshikuni Yamamoto Japan 10 47 0.6× 64 0.9× 76 1.1× 74 1.2× 74 1.5× 12 382
Xiao Xiang Yan China 12 73 0.9× 76 1.1× 129 1.8× 95 1.5× 44 0.9× 16 463
Myoung Ju Koh South Korea 9 88 1.1× 89 1.2× 78 1.1× 54 0.9× 36 0.8× 14 412

Countries citing papers authored by Miho Yano

Since Specialization
Citations

This map shows the geographic impact of Miho Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Yano more than expected).

Fields of papers citing papers by Miho Yano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Yano. The network helps show where Miho Yano may publish in the future.

Co-authorship network of co-authors of Miho Yano

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Yano. A scholar is included among the top collaborators of Miho Yano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Yano. Miho Yano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Okada, Hiroshi, Masahide Hamaguchi, Yoshitaka Hashimoto, et al.. (2023). Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort. Diabetes Research and Clinical Practice. 202. 110794–110794. 6 indexed citations
2.
Nakajima, Hanako, Hiroshi Okada, Akinori Kogure, et al.. (2022). Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study. SHILAP Revista de lepidopterología. 3(4). 620–633. 2 indexed citations
3.
Kondo, Shunsuke, et al.. (2015). Assessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapy. BMC Research Notes. 8(1). 315–315. 17 indexed citations
4.
Hasegawa, Goji, Yoshio Yamamoto, Jianguo Zhi, et al.. (2005). Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. Acta Diabetologica. 42(4). 179–181. 28 indexed citations
6.
Hasegawa, Goji, Hiroshi Obayashi, Akane Kitamura, et al.. (2002). Leukocyte–endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 16(5). 333–337. 15 indexed citations
7.
Hasegawa, Goji, Hiroshi Obayashi, A. Kitamura, et al.. (2002). Intercellular adhesion molecule‐1 (ICAM‐1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabetic Medicine. 19(5). 371–376. 49 indexed citations
8.
Kitamura, A., Goji Hasegawa, Hiroshi Obayashi, et al.. (2002). Interleukin‐6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in Type 2 diabetes. Diabetic Medicine. 19(12). 1000–1005. 106 indexed citations
9.
Aoki, Keiko, et al.. (2002). [A case of primary pulmonary proteinosis with bilateral pneumothorax].. PubMed. 40(5). 373–7. 2 indexed citations
10.
Matsumoto, Kazunari, Seibei Miyake, Miho Yano, et al.. (1999). Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.. Diabetes Care. 22(7). 1191–1195. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026